Verastem, Inc. (LON:0LOV)
5.97
-0.23 (-3.71%)
Feb 12, 2026, 4:19 PM GMT
Verastem Revenue
Verastem had revenue of $11.24M USD in the quarter ending September 30, 2025. In the year 2024, Verastem had annual revenue of $10.00M.
Revenue
$10.00M
Revenue Growth
+33.79%
P/S Ratio
33.24
Revenue / Employee
$128.21K
Employees
78
Market Cap
330.89M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.00M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 2.60M | 543.00K | 26.45% |
| Dec 31, 2021 | 2.05M | -86.46M | -97.68% |
| Dec 31, 2020 | 88.52M | 71.06M | 407.08% |
| Dec 31, 2019 | 17.46M | -9.26M | -34.67% |
| Dec 31, 2018 | 26.72M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Advanced Medical Solutions Group | 220.30M |
| Craneware | 150.11M |
| Integrated Diagnostics Holdings | 114.96M |
| Tristel | 46.46M |
Verastem News
- 7 days ago - Verastem Inc (VSTM) CEO Dan Paterson Sells 970 Shares - GuruFocus
- 8 days ago - Verastem (VSTM) Makes Strides with Innovative Cancer Treatments - GuruFocus
- 8 days ago - Verastem posts preliminary 2025 revenue, plans clinical updates in 2026 - Seeking Alpha
- 8 days ago - Verastem Oncology Provides Preliminary Fourth Quarter and 2025 Revenue and Business Updates and Outlines 2026 Strategic Priorities for Novel Portfolio Targeting RAS/MAPK Pathway-Driven Cancers - Business Wire
- 4 weeks ago - Insider Sell: Dan Paterson Sells Shares of Verastem Inc (VSTM) - GuruFocus
- 4 weeks ago - Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Polar Capital Holdings Plc Increases Stake in Verastem Inc - GuruFocus
- 6 weeks ago - Verastem: Downgrading To Buy Based On RAMP-203 Setback In Targeting KRAS G12C NSCLC - Seeking Alpha